Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Pyrethrum plant derived material or plant derived rotenone...
Patent
1995-06-01
1997-10-14
Rories, Charles C.P.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Pyrethrum plant derived material or plant derived rotenone...
514 46, 514 47, 436 94, 435 6, 435 911, 435199, 4352402, 536 245, 536 252, A61K 3170, A61K 4800, C07H 2100, C12Q 168
Patent
active
056772890
ABSTRACT:
A method of using a chimeric molecule made up of an antisense oligonucleotide attached to a 2',5'-oligoadenylate molecule to specifically cleave a sense strand of RNA, wherein the antisense oligonucleotide of the chimeric molecule is hybridized to the sense strand of RNA in the presence of 2',5'-dependent RNase.
REFERENCES:
Dialog File 636: IAC Newsletter DB (TM), #02944476-"Conference Coverage (ICAAC) Antisense Drug Stumbles in Early Trial".
R. Weiss, Science News, vol. 139 (Feb. 16, 1991) pp. 108-109.
C. Stein et al., Science, vol. 261 (Aug. 20, 1993) pp. 1004-1012.
M. Johnston et al., Interferon, vol. 3 (1984) pp. 332-334 & ref pages.
P. Defilippi et al., FEBS Letters, vol. 198(2) (Mar. 1986) pp. 326-332.
J. Chebath et al., Nature, vol. 330 (Dec. 10, 1987) pp. 587-588.
E. Uhlmann et al., Chem. Rev., vol. 90 (4) (Jun. 1990) pp. 543-584.
P. Westermann et al., Biomed. Biochem. Acta, vol. 48(1) (1989) pp. 85-93.
B. Tseng et al., Cancer Gene Therapy, vol. 1 (1) (Mar. 1994) pp. 65-71.
D. Krause et al., JBC, vol. 260(16) (Aug. 5, 1984) pp. 9501-9507.
P. Torrence et al., JBC, vol. 263(3) pp. 1131-1139 (1989).
K. Kariko et al., Biochem, vol. 25 (1986) pp. 3730-3736.
D. Wreschner et al., Nature, vol. 289(1981) pp. 414-417.
Y. Li et al., PNAS, vol. 89 (Apr. 1992) pp. 3185-3189.
R. Walder et al, PNAS, vol. 85 (Jul. 1988) pp. 5011-5015.
J. Goodchild et al., vol. 1(3) BioOrganic Chem, (90) pp. 165-187.
P. Miller et al., Anticancer Drug Design (1987) vol. 2, pp. 117-128.
Lesiak Krystyna
Maitra Ratan
Silverman Robert
Torrence Paul
Rories Charles C.P.
The Cleveland Clinic Foundation
The United States of America
LandOfFree
Method of cleaving specific strands of RNA and medical treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of cleaving specific strands of RNA and medical treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of cleaving specific strands of RNA and medical treatment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1555390